BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 1999
View Archived Issues
Positive study results obtained for Andrographolide + AZT
Read More
Cortecs discontinues Macritonin development and refocuses resources
Read More
Viagra is effective in treating ED in men with depression
Read More
NCI scientists on track to develop a vaccine to prevent, treat genital warts and cervical cancer
Read More
CombiChem and Icos expand collaboration
Read More
AxyS initiates phase II human clinical trials of APC-2059 for treatment of psoriasis
Read More
Matrix broadens phase II clinical trial program for FMdC to include colorectal cancer
Read More
Maxygen receives milestone payment from Pfizer
Read More
BioMarin subsidiary acquires biochemical reagent business from Oxford GlycoSciences
Read More
Significant antitumor response shown in preclinical study of prostate cancer treatment
Read More
News from DDW: effects of a 5-HT4 receptor antagonist on GI function in volunteers
Read More
Astressin B: a potential treatment for stress-induced gastrointestinal disturbances
Read More
Alza submits NDA for Viadur prostate cancer treatment
Read More
Bayer and Takeda launch cerivastatin in Japan
Read More
Zelmac featured in multiple presentations at DDW
Read More
Cenestin expected to be available in pharmacies by June 1, 1999
Read More
New compounds synthesized at JT promote osteogenesis
Read More
Cephalon develops compounds for muscle wasting
Read More
DNA ligase inhibitors with alpha-pyrone structure in development at Millennium
Read More
Dopamine D4 receptor ligands useful for schizophrenia claimed by Neurogen and Schering-Plough
Read More
Merck's new carbapenems particularly active against methicillin-resistant Gram-positive pathogens
Read More
Pierre Fabre strengthens R&D programs; company pipeline in review
Read More
Novel bicyclic compounds useful for lipid disorders, diabetes, obesity, etc.
Read More
New antifungal azole compounds developed in China
Read More
Potent new quinolone antibacterial agents synthesized at Shanghai Institute of Materia Medica
Read More
New gerontogene discovered by GenoPlex; further study funded by NIH
Read More
Survival advantage for exemestane observed in phase III breast cancer trial reported at ASCO meeting
Read More
RotaShield vaccine receives marketing authorization in Europe
Read More
PD-098059 inhibits AII-induced MAPK activation in myocardial cells
Read More
Long-term AT1 receptor blockade with fonsartan proves highly beneficial in SHR-SP
Read More
More news from ASCO: safety and pharmacokinetics of squalamine examined in phase I trials
Read More